These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21108389)

  • 1. The emergence of pharmacotherapies for cognitive function in Down syndrome.
    Capone GT
    Am J Med Genet A; 2010 Dec; 152A(12):3026-7. PubMed ID: 21108389
    [No Abstract]   [Full Text] [Related]  

  • 2. Donepezil for treatment of cognitive dysfunction in children with Down syndrome aged 10-17.
    Kishnani PS; Heller JH; Spiridigliozzi GA; Lott I; Escobar L; Richardson S; Zhang R; McRae T
    Am J Med Genet A; 2010 Dec; 152A(12):3028-35. PubMed ID: 21108390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donepezil for Down's syndrome.
    Kishnani PS; Spiridigliozzi GA; Heller JH; Sullivan JA; Doraiswamy PM; Krishnan KR
    Am J Psychiatry; 2001 Jan; 158(1):143. PubMed ID: 11136652
    [No Abstract]   [Full Text] [Related]  

  • 4. Donepezil use in the treatment of dementia associated with Down syndrome.
    Cipriani G; Bianchetti A; Trabucchi M
    Arch Neurol; 2003 Feb; 60(2):292; author reply 292. PubMed ID: 12580720
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of donepezil on cognitive functioning in Down syndrome.
    Johnson N; Fahey C; Chicoine B; Chong G; Gitelman D
    Am J Ment Retard; 2003 Nov; 108(6):367-72. PubMed ID: 14561111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donepezil minimally effective for patients with vascular dementia.
    Johnson KD
    J Fam Pract; 2004 Mar; 53(3):181-2. PubMed ID: 15000918
    [No Abstract]   [Full Text] [Related]  

  • 7. Preliminary study of the safety and efficacy of donepezil hydrochloride in children with Down syndrome: a clinical report series.
    Spiridigliozzi GA; Heller JH; Crissman BG; Sullivan-Saarela JA; Eells R; Dawson D; Li J; Kishnani PS
    Am J Med Genet A; 2007 Jul; 143A(13):1408-13. PubMed ID: 17542008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse effects of donepezil in treating Alzheimer's disease associated with Down's syndrome.
    Hemingway-Eltomey JM; Lerner AJ
    Am J Psychiatry; 1999 Sep; 156(9):1470. PubMed ID: 10484967
    [No Abstract]   [Full Text] [Related]  

  • 9. [Donepezil as treatment of Charles Bonnet syndrome].
    Santos-Bueso E; Serrador-García M; García-Sánchez J
    Arch Soc Esp Oftalmol; 2013 Sep; 88(9):369-70. PubMed ID: 23988046
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroleptic malignant-like syndrome due to donepezil and maprotiline.
    Ohkoshi N; Satoh D; Nishi M; Shoji S
    Neurology; 2003 Mar; 60(6):1050-1. PubMed ID: 12654986
    [No Abstract]   [Full Text] [Related]  

  • 11. Donepezil for cognitive impairment in Parkinson's disease: a randomized controlled trial.
    Marder K
    Curr Neurol Neurosci Rep; 2002 Sep; 2(5):390-1. PubMed ID: 12169217
    [No Abstract]   [Full Text] [Related]  

  • 12. Donepezil: an update.
    Seltzer B
    Expert Opin Pharmacother; 2007 May; 8(7):1011-23. PubMed ID: 17472546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donepezil use in Down syndrome.
    Kishnani PS; Sullivan JA; Spiridigliozzi GA; Heller JH; Crissman BG
    Arch Neurol; 2004 Apr; 61(4):605-6. PubMed ID: 15096417
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic advances: donepezil for the treatment of Alzheimer's disease.
    Misson J; Kendall MJ
    J Clin Pharm Ther; 1997 Aug; 22(4):251-5. PubMed ID: 9548205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer's disease in adults with Down syndrome: open label study.
    Prasher VP; Adams C; Holder R;
    Int J Geriatr Psychiatry; 2003 Jun; 18(6):549-51. PubMed ID: 12789681
    [No Abstract]   [Full Text] [Related]  

  • 16. Donepezil use in Alzheimer disease.
    Barner EL; Gray SL
    Ann Pharmacother; 1998 Jan; 32(1):70-7. PubMed ID: 9475825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease--pilot study.
    Prasher VP; Huxley A; Haque MS;
    Int J Geriatr Psychiatry; 2002 Mar; 17(3):270-8. PubMed ID: 11921156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long-term efficacy and tolerability of donepezil in patients with vascular dementia.
    Wilkinson D; Róman G; Salloway S; Hecker J; Boundy K; Kumar D; Posner H; Schindler R
    Int J Geriatr Psychiatry; 2010 Mar; 25(3):305-13. PubMed ID: 19623601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donepezil for severe Alzheimer's disease.
    Opie LH
    Lancet; 2006 Jul; 368(9533):361-2; author reply 362. PubMed ID: 16876651
    [No Abstract]   [Full Text] [Related]  

  • 20. Donepezil in the treatment of mild to moderate Alzheimer's disease: report of a Belgian multicenter study.
    Santens P; Ventura M
    Acta Neurol Belg; 2003 Sep; 103(3):159-63. PubMed ID: 14626696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.